Association between gut microbiota and preeclampsia-eclampsia: a two-sample Mendelian randomization study.
Li P, Wang H, Guo L, Gou X, Chen G, Lin D, Fan D, Guo X, Liu Z. · 2022
Read Association between gut microbiota and preeclampsia-eclampsia: a two-sample Mendelian randomization study. by Li P, Wang H, Guo L, Gou X, Chen G, Lin D, Fan D, Guo X, Liu Z. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9667679.txt.
Introduction
Li and co-authors test gut bacteria for causal links to preeclampsia-eclampsia with two-sample Mendelian randomization. Watch studies had tied gut mix to the pregnancy disorder. Such studies cannot prove which side drives the link. Genetic instruments offer a way to probe cause.
Bacteria data came from a genome-wide meta-analysis of 13,266 people. Outcome data came from FinnGen, with 5731 cases and 160,670 controls. Several methods weighed the genetic evidence in parallel. The main method tied Bifidobacterium to a guard effect. Its odds ratio for the disorder was 0.76 in the lead test. Five other bacteria groups showed hints of guard effects. Reverse tests found no pull from the disorder back to gut mix. The authors call for trials of probiotics in pregnancy care. Such trials can test the guard claim head on.
Catalog record
| CREATOR | Li P, Wang H, Guo L, Gou X, Chen G, Lin D, Fan D, Guo X, Liu Z. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Association between gut microbiota and preeclampsia-eclampsia: a two-sample Mendelian randomization study By Pengsheng Li, Haiyan Wang, Lan Guo, Xiaoyan Gou, Gengdong Chen, Dongxin Lin, Dazhi Fan, Xiaoling Guo, Zhengping Liu Published in: BMC Medicine DOI: 10.1186/s12916-022-02657-x ABSTRACT Background Several recent observational studies have reported that gut microbiota composition is associated with preeclampsia. However, the causal effect of gut microbiota on preeclampsia-eclampsia is unknown. Methods A two-sample Mendelian randomization study was performed using the summary statistics of gut microbiota from the largest available genome-wide association study meta-analysis (n=13,266) conducted by the MiBioGen consortium. The summary statistics of preeclampsia-eclampsia were obtained from the FinnGen consortium R7 release data (5731 cases and 160,670 controls). Inverse variance weighted, maximum likelihood, MR-Egger, weighted median, weighted model, MR-PRESSO, and cML-MA were used to examine the causal association between gut microbiota and preeclampsia-eclampsia. Reverse Mendelian randomization analysis was performed on the bacteria that were found to be causally associated with preeclampsia-eclampsia in forward Mendelian randomization analysis. Cochran’s Q statistics were used to quantify the heterogeneity of instrumental variables. Results Inverse variance weighted estimates suggested that Bifidobacterium had a protective effect on preeclampsia-eclampsia (odds ratio = 0.76, 95% confidence interval: 0.64–0.89, P = 8.03 × 10−4). In addition, Collinsella (odds ratio = 0.77, 95% confidence interval: 0.60–0.98, P = 0.03), Enterorhabdus (odds ratio = 0.76, 95% confidence interval: 0.62–0.93, P = 8.76 × 10−3), Eubacterium (ventriosum group) (odds ratio = 0.76, 95% confidence interval: 0.63–0.91, P = 2.43 × 10−3), Lachnospiraceae (NK4A136 group) (odds ratio = 0.77, 95% confidence interval: 0.65–0.92, P = 3.77 × 10−3), and Tyzzerella 3 (odds ratio = 0.85, 95% confidence interval: 0.74–0.97, P = 0.01) presented a suggestive association with preeclampsia-eclampsia. According to the results of reverse MR analysis, no significant causal effect of preeclampsia-eclampsia was found on gut microbiota. No significant heterogeneity of instrumental variables or horizontal pleiotropy was found. Conclusions This two-sample Mendelian randomization study found that Bifidobacterium was causally associated with preeclampsia-eclampsia. Further randomized controlled trials are needed to clarify the protective effect of probiotics on preeclampsia-eclampsia and their specific protective mechanisms. Supplementary Information The online version contains supplementary material available at 10.1186/s12916-022-02657-x. BACKGROUND Preeclampsia and eclampsia (PE) are serious complications of pregnancy that affect 3–8% of pregnancies worldwide [1, 2] and are the leading causes of maternal and neonatal death [3, 4]. PE increases the risk of adverse pregnancy outcomes, including preterm birth and low birth weight [5]. It is also associated with serious maternal and child health problems, such as chronic hypertension, myocardial ischemia, and end-stage kidney disease in mothers [6, 7], as well as bronchopulmonary dysplasia and cognitive impairment in offspring [7, 8]. The pathogenesis of PE is still not fully understood. A variety of mechanisms including failure of spiral artery remodeling [9], imbalance of vascular endothelial growth factor (VEGF) and soluble fms-like tyrosine kinase 1 (sFlt1) [10], placental oxidative stress [11], and immune dysregulation [12] are believed to be involved. Moreover, PE is considered a progressive disease in which symptoms and organ function deteriorate over time and are cured only by delivery [1]. The gut microbiome has been observed to change significantly during pregnancy [13] and plays an important role in both maternal and fetal health [14]. Multiple studies have found that Bifidobacterium has a protective effect on PE [15–17]. Further research on probiotics and prebiotics may contribute to the prevention and treatment of PE. However, the results of published studies are not consistent. For example, unlike other studies, Altemani et al. found that Bifidobacterium increased in PE patients [16]. Miao and Lv et al. found that Blautia is a risk factor for PE [18, 19], while Chang and Yu reported the opposite result [20, 21]. Most previous studies were designed as case-control studies, and the timing of exposure and outcome is difficult to confirm. In addition, in observational studies, the association between gut microbiota and PE is susceptible to confounding factors such as age, environment, dietary patterns, and lifestyle [22], and it is difficult to effectively control these factors in an observational study. These conditions limit the causal inference between the gut microbiota and PE. In this context, Mendelian randomization (MR) is a novel approach to explore the causal association between gut microbiota and PE. MR uses genetic variants to construct instrumental variables of exposure to estimate the causal association between exposure and disease outcome [23]. Because the allocation of genotypes from parent to offspring is random, the association between genetic variants and outcome is not affected by common confounding factors, and a causal sequence is reasonable [24]. MR has been widely applied to explore the causal association between gut microbiota and diseases, including metabolic diseases [25], autoimmune diseases [26], and rheumatoid arthritis [27]. In this study, using the genome-wide association study (GWAS) summary statistics from the MiBioGen and FinnGen consortiums, a two-sample MR analysis was conducted to evaluate the causal association between gut microbiota and PE. METHODS Data sources Genetic variants for gut microbiota were obtained from the largest genome-wide meta-analysis published to date for gut microbiota composition conducted by the MiBioGen consortium [28, 29]. The study included 18,340 individuals from 24 cohorts, most of whom had European ancestry (n = 13,266), targeting variable regions V4, V3–V4, and V1–V2 of the 16S rRNA gene to profile the microbial composition and to conduct taxonomic classification using direct taxonomic binning. Microbiota quantitative trait loci (mbQTL) mapping analysis was conducted to identify host genetic variants that were mapped to genetic loci associated with the abundance levels of bacterial taxa in the gut microbiota. In the study, genus was the lowest taxonomic level, and 131 genera with a mean abundance greater than 1% were identified, which included 12 unknown genera [28]. Therefore, 119 genus-level taxa were included in the current study for analysis. GWAS summary statistics for PE were obtained from FinnGen consortium R7 release data [30, 31]. The phenotype “pre-eclampsia or eclampsia” was adopted in the current study. This GWAS included 166,401 Finnish adult female subjects and consisted of 5731 cases and 160,670 controls. Sex, age, first 10 principal components, and genotyping batch were corrected during the analysis [30]. Instrumental variable (IV) The following selection criteria were used to choose the IVs: (1) single nucleotide polymorphisms (SNPs) associated with each genus at the locus-wide significance threshold (P < 1.0×10–5) were selected as potential IVs [25]; (2) 1000 Genomes project European samples data were used as the reference panel to calculate the linkage disequilibrium (LD) between the SNPs, and among those SNPs that had R2 < 0.001 (clumping window size=10,000 kb), only the SNPs with the lowest P-values were retained; (3) SNPs with minor allele frequency (MAF) ≤ 0.01 were removed; and (4) when palindromic SNPs existed, the forward strand alleles were inferred using allele frequency information. Statistical analysis In this study, multiple methods including inverse variance weighted (IVW), maximum likelihood (ML), MR-Egger regression, weighted median, weighted model, MR-PRESSO, and cML-MA were used to examine whether there was a causal association between gut microbiota and PE. The IVW method used a meta-analysis approach combined with the Wald estimates for each SNP to obtain an overall estimate of the effect for gut microbiota on PE. If horizontal pleiotropy was not present, the IVW results would be unbiased [32]. The